[go: up one dir, main page]

ECSP056101A - Composiciones y metodos de formulacion para formulas enterales que contienen acido sialico - Google Patents

Composiciones y metodos de formulacion para formulas enterales que contienen acido sialico

Info

Publication number
ECSP056101A
ECSP056101A EC2005006101A ECSP056101A ECSP056101A EC SP056101 A ECSP056101 A EC SP056101A EC 2005006101 A EC2005006101 A EC 2005006101A EC SP056101 A ECSP056101 A EC SP056101A EC SP056101 A ECSP056101 A EC SP056101A
Authority
EC
Ecuador
Prior art keywords
sialic acid
formulation
compositions
methods
formulas containing
Prior art date
Application number
EC2005006101A
Other languages
English (en)
Inventor
Mary Frances Locniskar
Steven Charles Rumsey
Robert J Mcmahon
Joshua C Anthony
Ratchapong Wungtanagorn
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of ECSP056101A publication Critical patent/ECSP056101A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/16—Agglomerating or granulating milk powder; Making instant milk powder; Products obtained thereby
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Pediatric Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)

Abstract

Se describe una fórmula para infantes nutricionalmente completa que contiene ácido siálico derivado de una fuente o un número de fuentes apropiada en nutrientes.
EC2005006101A 2003-04-14 2005-10-14 Composiciones y metodos de formulacion para formulas enterales que contienen acido sialico ECSP056101A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/413,508 US7867541B2 (en) 2003-04-14 2003-04-14 Compositions and methods of formulation for enteral formulas containing sialic acid

Publications (1)

Publication Number Publication Date
ECSP056101A true ECSP056101A (es) 2006-03-01

Family

ID=33131416

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2005006101A ECSP056101A (es) 2003-04-14 2005-10-14 Composiciones y metodos de formulacion para formulas enterales que contienen acido sialico

Country Status (21)

Country Link
US (1) US7867541B2 (es)
EP (1) EP1613169B1 (es)
KR (1) KR101087332B1 (es)
CN (1) CN100515216C (es)
AR (1) AR043846A1 (es)
AT (1) ATE469560T1 (es)
BR (1) BRPI0409309B1 (es)
CA (1) CA2522091C (es)
CL (1) CL2004000803A1 (es)
DE (1) DE602004027476D1 (es)
DK (1) DK1613169T3 (es)
EC (1) ECSP056101A (es)
ES (1) ES2346533T3 (es)
MX (1) MXPA05010806A (es)
MY (1) MY154371A (es)
NO (1) NO330441B1 (es)
PL (1) PL1613169T3 (es)
PT (1) PT1613169E (es)
RU (1) RU2361408C2 (es)
TW (1) TWI369183B (es)
WO (1) WO2004093557A1 (es)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE228779T1 (de) * 1999-01-20 2002-12-15 Nutricia Nv Säuglingsnährpräparat
AU2002219304A1 (en) * 2000-12-13 2002-06-24 Institut D'optique Theorique Et Appliquee Method for characterising a surface, and device therefor
US20100268658A1 (en) * 2001-05-14 2010-10-21 Prolacta Bioscience Method for collecting, testing and distributing milk
US7951410B2 (en) 2003-04-14 2011-05-31 Mead Johnson Nutrition Company Enteral compositions containing caseinoglycomacropeptide having an enhanced concentration of sialic acid
DE102004040452A1 (de) * 2004-08-20 2006-02-23 N.V. Nutricia Peptidgemisch
IN2012DN02663A (es) * 2004-10-12 2015-09-11 Fonterra Co Operative Group
US20060246146A1 (en) * 2005-04-29 2006-11-02 Mcmahon Robert J Method of increasing the salivary sialic acid content in a mammal
US20060247153A1 (en) * 2005-04-29 2006-11-02 Mcmahon Robert J Method of improving learning and memory in mammals
AU2006251569B2 (en) 2005-05-23 2012-06-21 Massachusetts Institute Of Technology Compostions containing pufa and/or uridine and methods of use thereof
EP1926834A4 (en) 2005-09-20 2009-04-22 Prolacta Bioscience Inc METHOD FOR ANALYZING MILK
US7829126B2 (en) * 2005-10-26 2010-11-09 Abbott Laboratories Infant formulas containing docosahexaenoic acid and lutein
US20070104843A1 (en) * 2005-11-04 2007-05-10 Holst Hans H Concentrate derived from a milk product enriched in naturally occurring sialyllactose and a process for preparation thereof
PT1972346E (pt) * 2005-11-30 2016-02-03 Vegenat S A Mistura proteica e a sua utilização na preparação de um produto que é destinado a alimento oral ou entérico
ATE509624T1 (de) * 2005-12-23 2011-06-15 Nutricia Nv Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz
US20080003330A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Infant formulas for early brain development
DK3485742T3 (da) * 2006-11-29 2021-11-15 Prolacta Bioscience Inc Modermælkssammensætninger og fremgangsmåder til fremstilling og anvendelse deraf
WO2008073888A2 (en) 2006-12-08 2008-06-19 Prolacta Bioscience, Inc. Compositions of human lipids and methods of making and using same
NZ581390A (en) * 2007-06-25 2012-09-28 Dsm Ip Assets Bv Prebiotics comprising an oligosaccharide, sialyloligosaccharide and free sialic acid
PT2190304E (pt) * 2007-09-17 2012-03-20 Nutricia Nv Formulação nutricional com alto teor energético
ES2811549T3 (es) * 2007-10-19 2021-03-12 Fonterra Cooperative Group Ltd Métodos de mantenimiento o aumento del crecimiento o desarrollo cognitivo
EP2096115A1 (en) * 2008-02-26 2009-09-02 Nestec S.A. Oligosaccharide ingredient
KR101116864B1 (ko) * 2008-08-01 2012-02-29 주식회사 베네비오 고지혈증, 지방간 또는 비만의 예방 또는 치료용 조성물
EP2183984B1 (en) * 2008-11-10 2011-12-28 Nestec S.A. Sialic acid producing bacteria
WO2010065652A1 (en) 2008-12-02 2010-06-10 Prolacta Bioscience, Inc. Human milk permeate compositions and methods of making and using same
US8293264B2 (en) * 2009-05-11 2012-10-23 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
KR101158472B1 (ko) * 2009-11-05 2012-06-20 주식회사 베네비오 알코올에 유발된 간질환의 예방 또는 치료용 조성물
BR112012023004A2 (pt) * 2010-03-12 2015-09-15 Dsm Ip Assets Bv suplementação maternal de ácido siálico.
WO2011121151A1 (es) * 2010-03-31 2011-10-06 Vegenat, S.A. Suplemento alimenticio funcional especialmente destinado para la nutrición, prevención y mejora en casos de alteraciones neurológicas, neurodegenerativas o trastornos cognitivos
EP2554057A4 (en) * 2010-03-31 2013-12-18 Vegenat S A ENERAL OR ORAL FOOD PRODUCT SPECIALLY FOR NUTRITION, PREVENTION AND MITIGATION OF NEUROLOGICAL OR NEURODEGENERATIVE ALTERATIONS OR COGNITIVE DISORDERS
SG191799A1 (en) 2010-12-31 2013-08-30 Abbott Lab Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof
MX356994B (es) 2010-12-31 2018-06-22 Abbott Lab Composiciones nutricionales que comprenden los oligosacaridos de leche humana y los nucleotidos y los usos de las mismas para tratar y/o prevenir la infeccion viral enterica.
EP2658547A1 (en) 2010-12-31 2013-11-06 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
US11337990B2 (en) 2010-12-31 2022-05-24 Abbott Laboratories Human milk oligosaccharides to promote growth of beneficial bacteria
MY166946A (en) 2010-12-31 2018-07-25 Abbott Lab Methods of using human milk oligosaccharides for improving airway respiratory health
EP3338784B1 (en) 2010-12-31 2020-07-22 Abbott Laboratories Human milk oligosaccharides for modulating inflammation
DK2658549T3 (da) 2010-12-31 2020-06-29 Abbott Lab Fremgangsmåder til reduktion af incidensen af oxidativt stress under anvendelse af humane mælkeoligosaccharider, vitamin c og anti-inflammatoriske midler
PH12013501501A1 (en) * 2011-02-10 2019-10-07 Nestec Sa Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk
EP2726597B1 (en) * 2011-06-30 2017-11-15 Chr. Hansen A/S Drying lactic acid bacteria and compositions
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
CN103813796A (zh) 2011-07-22 2014-05-21 雅培制药有限公司 用于预防胃肠道损伤和/或促进胃肠道修复的低聚半乳糖
ES2655019T3 (es) 2011-08-03 2018-02-16 Prolacta Bioscience, Inc. Microfiltración de leche humana para reducir la contaminación bacteriana
CA2846603A1 (en) 2011-08-29 2013-03-07 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
US20140179782A1 (en) * 2011-10-14 2014-06-26 Mead Johnson Nutrition Company Neurogenesis screening method and uses thereof
RU2620370C2 (ru) 2011-12-14 2017-05-25 Нестек С.А. Эмульгированный пищевой продукт, содержащий молочный белок
US20140179775A1 (en) * 2012-02-29 2014-06-26 Mead Johnson Nutrition Company Neurogenesis screening method and uses thereof
US9351978B2 (en) * 2012-02-29 2016-05-31 Mead Johnson Nutrition Company Neurogenesis screening method and uses thereof
NZ630210A (en) 2012-03-14 2016-05-27 Abbott Lab Nutritional compositions including rrr -alpha tocopherol and polyunsaturated fatty acids
SE536599C3 (sv) * 2012-04-10 2017-01-10 Hero Ag Näringssammansättning med lågt kalori- och lågt proteininnehåll
MY169122A (en) 2013-03-13 2019-02-18 Abbott Lab Infant nutritional product with rrr alpha-tocopherol
FI3821713T3 (fi) 2013-03-13 2025-03-27 Prolacta Bioscience Inc Runsasrasvaisia äidinmaitotuotteita
WO2014159967A1 (en) * 2013-03-13 2014-10-02 Abbott Laboratories A composition for enhancing newborn infant cognitive, brain and/or cns development and method of using same
CN103478251B (zh) * 2013-07-23 2015-03-25 东北农业大学 一种含唾液酸婴儿配方奶粉的制备方法
CN104187742A (zh) * 2014-07-09 2014-12-10 上海育生堂科技有限公司 一种用于促进青少年儿童成长和改善大脑发育的食用组合物
MX377227B (es) 2014-09-25 2025-03-07 Soc Des Produits Nestle S A Star Sistema de formulas infantiles con niveles adaptables de oligosacaridos de la leche humana (hmo).
WO2016145628A1 (en) * 2015-03-18 2016-09-22 Nestec S.A. Composition comprising siallyllactose for use in enhancing learning skills and memory function
US10525016B2 (en) 2015-06-03 2020-01-07 Mead Johnson Nutrition Company Nutritional compositions containing an elevated level of inositol and uses thereof
US20170006897A1 (en) 2015-07-10 2017-01-12 Mead Johnson Nutrition Company Nutritional compositions and methods for promoting cognitive development
US10582714B2 (en) 2015-07-10 2020-03-10 Mead Johnson Nutrition Company Nutritional compositions and methods for promoting cognitive development
US10034937B2 (en) 2015-12-04 2018-07-31 Mead Johnson Nutrition Company Synergistic nutritional compositions and uses thereof
US11478011B2 (en) * 2015-12-14 2022-10-25 Societe Des Produits Nestle S.A. Nutritional compositions and infant formula for promoting de novo myealination
JP7356221B2 (ja) 2015-12-30 2023-10-04 プロラクタ バイオサイエンス，インコーポレイテッド 術前及び術後のケアに有用なヒト乳製品
CN106615146A (zh) * 2016-09-01 2017-05-10 西安银桥乳业（集团）有限公司 一种添加组合益生元的婴幼儿配方奶粉及其制备方法
US20180160714A1 (en) 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
US20180161292A1 (en) 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
US20180168215A1 (en) 2016-12-21 2018-06-21 Mead Johnson Nutrition Company Nutritional compositions containing inositol and uses thereof
US20180332881A1 (en) 2017-05-17 2018-11-22 Mead Johnson Nutrition Company Preterm infant formula containing butyrate and uses thereof
CN107467667B (zh) * 2017-07-17 2018-06-26 北京亦贝安生物医药科技有限公司 一种含有两种不饱和脂肪酸和唾液酸的复方制剂
EP3473644A1 (en) * 2017-10-17 2019-04-24 Jennewein Biotechnologie GmbH Fermentative production of n-acetylneuraminic acid
US20190208807A1 (en) 2018-01-05 2019-07-11 Mead Johnson Nutrition Company Nutritional compositions containing milk-derived peptides and uses thereof
GB2573538B (en) 2018-05-09 2023-01-04 Mjn Us Holdings Llc Pediatric nutritional compositions and methods for infants delivered by C-section
US12364721B2 (en) 2019-09-24 2025-07-22 Prolacta Bioscience, Inc. Compositions and methods for treatment of inflammatory and immune diseases
CN111011522A (zh) * 2020-02-27 2020-04-17 青岛索康食品有限公司 一种提高免疫力的儿童配方奶粉及其制备方法
CN113068747A (zh) * 2020-03-24 2021-07-06 北京三元食品股份有限公司 一种促进孕产妇和婴幼儿健康的孕产妇配方乳粉

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4762822A (en) * 1985-08-08 1988-08-09 Ettinger Anna C Reduction of gastrointestinal disease-producing organisms with sialic acid and gangliosides
DD273543A3 (de) * 1987-09-14 1989-11-22 Univ Rostock Verfahren zur herstellung von saeuglings- und diaetnahrungen mit hypoantigener, bifidogener wirkung
DE3876986D1 (de) * 1988-07-07 1993-02-04 Milupa Ag Verfahren zur enzymatischen herstellung von bifidogener saeuglings- und diaetnahrung.
US6020015A (en) * 1988-09-22 2000-02-01 Gaull; Gerald E. Infant formula compositions and nutrition containing genetically engineered human milk proteins
EP0481038B1 (en) * 1990-04-16 2002-10-02 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
CH681543A5 (es) * 1990-04-27 1993-04-15 Nestle Sa
JP3035833B2 (ja) * 1991-01-21 2000-04-24 雪印乳業株式会社 シアル酸類含有組成物の製造方法
JP3125451B2 (ja) * 1991-11-05 2001-01-15 ソニー株式会社 信号処理方法
JPH07277929A (ja) 1994-04-01 1995-10-24 Momotani Jiyuntenkan:Kk 育毛、養毛料
US5576300A (en) * 1994-09-16 1996-11-19 Abbott Laboratories Method for inhibition of human rotavirus infection
US5575916A (en) * 1994-11-07 1996-11-19 Neose Pharmaceuticals, Inc. Method of processing a cheese processing waste stream
US5849324A (en) * 1995-07-10 1998-12-15 Abbott Laboratories Use of indigestible oligosaccharides to reduce the incidence of otitis media in humans
EP0923315B1 (en) 1996-08-30 2003-12-10 Societe Des Produits Nestle S.A. Nutritional formula for phenylketonuria patients
ATE230935T1 (de) * 1997-07-22 2003-02-15 Nestle Sa Lipidzusammensetzung für säuglingsnährpräparat und herstellungsverfahren
US6168823B1 (en) * 1997-10-09 2001-01-02 Wisconsin Alumni Research Foundation Production of substantially pure kappa casein macropeptide
DK1048226T3 (da) 1999-04-29 2005-10-03 Nestle Sa Sammensætning til spædbörnsernæring indeholdende proteiner fra söd valle
US6288222B1 (en) * 2000-02-16 2001-09-11 Neose Technologies, Inc. Method of filtration of a dairy stream
JP2003522784A (ja) 2000-02-17 2003-07-29 ワイス プレバイオティック物質を含有する栄養配合物
US6592863B2 (en) * 2000-08-22 2003-07-15 Nestec S.A. Nutritional composition
GB0116509D0 (en) 2001-07-06 2001-08-29 Hannah Res Inst The Methods of extracting casein fractions from milk and caseinates and production of novel products

Also Published As

Publication number Publication date
HK1091376A1 (zh) 2007-01-19
TWI369183B (en) 2012-08-01
RU2005135122A (ru) 2006-03-10
AR043846A1 (es) 2005-08-17
CL2004000803A1 (es) 2005-05-06
RU2361408C2 (ru) 2009-07-20
CA2522091A1 (en) 2004-11-04
DK1613169T3 (da) 2010-09-20
CN1802094A (zh) 2006-07-12
EP1613169B1 (en) 2010-06-02
PT1613169E (pt) 2010-06-17
BRPI0409309B1 (pt) 2020-09-15
MXPA05010806A (es) 2005-12-05
CN100515216C (zh) 2009-07-22
KR101087332B1 (ko) 2011-11-25
EP1613169A1 (en) 2006-01-11
MY154371A (en) 2015-06-15
TW200503631A (en) 2005-02-01
PL1613169T3 (pl) 2010-11-30
KR20060006921A (ko) 2006-01-20
ES2346533T3 (es) 2010-10-18
NO20055335L (no) 2006-01-03
US7867541B2 (en) 2011-01-11
ATE469560T1 (de) 2010-06-15
CA2522091C (en) 2011-10-11
DE602004027476D1 (de) 2010-07-15
US20040202765A1 (en) 2004-10-14
BRPI0409309A (pt) 2006-04-18
NO330441B1 (no) 2011-04-11
NO20055335D0 (no) 2005-11-11
WO2004093557A1 (en) 2004-11-04

Similar Documents

Publication Publication Date Title
ECSP056101A (es) Composiciones y metodos de formulacion para formulas enterales que contienen acido sialico
MY162034A (en) Compositions and methods of formulation for enteral formulas containing sialic acid
BR112022011421A2 (pt) Inibidores da proteína mutante kras
EA200701176A1 (ru) Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их
ECSP045182A (es) Procedimiento para la preparación de ésteres de escopina
MA33075B1 (fr) Composition destinee a la regulation du metabolism des lipides
BR0317891A (pt) Tratamento de ferimentos de pele usando polienilfosfatidil colina e alcanolaminas
ECSP088152A (es) 7-aza-indazoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización
BRPI0419305B8 (pt) compostos inibidores de p38, composições farmacêuticas compreendendo os mesmos e usos dos referidos compostos na preparação de medicamentos
BR0114635A (pt) Anticolinérgicos aplicáveis como medicamento bem como processo para a sua preparação
UY30681A1 (es) Compuestos de piridinamida que contienen carboxi, sales farmacéuticamente aceptables, procedimientos para la preparacion de los mismos, composiciones que los contienen y sus usos.
ECSP088252A (es) 7-aza-indazoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización
MXPA05010274A (es) Composiciones que contienen lactulosa para tratar infecciones por rotavirus.
CR7807A (es) Piperacinil y diacepanil benzamidas y benztioamidas
BRPI0507830A (pt) derivados azabicìclicos, o respectivo processo de preparo e as composições farmacêuticas que os contêm
UY30787A1 (es) "inhibidores benzoimidazolicos de trpv1"
ATE400272T1 (de) Piperidin-verbindungen als malonyl-coa decarboxylase-hemmer
BRPI0302496C1 (pt) composições farmacêuticas com atividade antibiótica
DOP2002000373A (es) Composiciones que contienen imidazotriazinona para administración nasal
BRPI0408848A (pt) formulações orais de cladribine
BRPI0411087A (pt) aperfeiçoamentos em ou relacionados a compostos orgánicos
GEP20074257B (en) Novel method for the synthesis of s-indoline-2-carboxylic acid and application thereof in the synthesis of perindopril
UY28422A1 (es) Sistemas emulsionantes que contienen derivados de azetidina
BR0308807A (pt) Compostos tiazol-2-il-imina como inibidores de pde-7
DK1537065T3 (da) Analoger af D-vitamin